Like in recent years, Celonic will participate at BIO 2010. Dr. Andreas Herrmann and Stefanie Hermann will especially attend the partnering and visit a number of companies in the greater Chicago area. Celonic has again broadened its portfolio in the last months. The Juelich facility has prepared to run analytical studies according to GMP. "We have been working according to GLP for some years to offer preclinical and clinical analytics which are essential for pharmacokinetics and pharmacodynamics. Now, we are additionally able to offer release analytics", states Andreas Herrmann. Celonic's production portfolio covers the complete range from cell-line development up to GMP production in a 1,000 Liters scale.